DGAP-News
STRATEC reports substantial growth in 2016 - Seite 2
bps = basis points
1 2016 figure adjusted for one-off items resulting from transaction activities and related reorganization expenses
2 2016 figure additionally adjusted for financing expenses and tax expenses in connection with the acquisitions of the Diatron Group and STRATEC Consumables, for one-off items resulting
from the tax audit for the 2009 to 2013 assessment periods, and for tax effects relating to reorganization expenses
STRATEC Biomedical AG can look back on a superb 2016 financial year, in which it substantially increased its sales and earnings while also significantly strengthening its strategic position. As well as expanding its development team, a prerequisite for implementing numerous forthcoming development projects, STRATEC also accessed major new business fields through the acquisition of two companies. For the current 2017 financial year, the company expects to generate further growth. Moreover STRATEC will be proposing what will be already the thirteenth consecutive increase in its dividend for approval by the Annual General Meeting to be held on June 14, 2017.
Business performance
STRATEC increased its sales year-on-year by 25.9% from EUR 146.9 million to EUR 184.9 million in the 2016 financial year. In addition to the boost resulting from the two subsidiaries acquired in
2016, Diatron and STRATEC Consumables, the Group's sales growth was also driven by higher sales in its service parts business as well as by further expansion in development services.
The share of sales generated by service parts and consumables rose from 25.9% in the previous year to 29.0% in 2016. This figure incorporates for the first time sales of consumables at the Diatron Group and at STRATEC Consumables.
Lesen Sie auch
EBIT grew year-on-year by 20.1% to EUR 32.3 million, corresponding to an EBIT margin of 17.5%. Benefits of scale rose significantly during recent months and had a notable impact on margin, especially in the fourth quarter of 2016. Consolidated net income showed a corresponding increase of14.9% to EUR 25.4 million, while earnings per share grew by 14.4% to EUR 2.14.